Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes.1 passage
• A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.1 passage
• A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn's Disease Flares.1 passage
• A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.1 passage
• A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.1 passage
• A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.1 passage
• A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.1 passage
• A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.1 passage
• A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.1 passage
• A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.1 passage
• A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.1 passage
• A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.1 passage
• A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.1 passage
• A Pilot Study on Automatic Three-Dimensional Quantification of Barrett's Esophagus for Risk Stratification and Therapy Monitoring.1 passage
• A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.1 passage
• A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study.1 passage
• A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.1 passage
• A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report.1 passage
• A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.1 passage
• A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction.1 passage
• A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance.1 passage
• A combination of molecular markers and clinical features improve the classification of pancreatic cysts.1 passage
• A model to determine colorectal cancer risk using common genetic susceptibility loci.1 passage
• AAA IBD 2017: Methodologies to Collect and Analyze Clinical Data to Support Quality Improvement Initiatives Designed to Optimize the Care of Patients With IBD.1 passage
• ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.1 passage
• ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.1 passage
• ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.1 passage
• AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D): Patient Summary.1 passage
• AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.1 passage
• AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.1 passage
• AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review.1 passage
• AGA Clinical Practice Update on Endoscopic Therapies for Non-Variceal Upper Gastrointestinal Bleeding: Expert Review.1 passage
• AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.1 passage
• AGA Clinical Practice Update on Functional Heartburn: Expert Review.1 passage
• AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.1 passage
• AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.1 passage
• AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.1 passage
• AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Review.1 passage
• AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.1 passage
• AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.1 passage
• AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review.1 passage
• AGA Clinical Practice Update on Strategies to Improve Quality of Screening and Surveillance Colonoscopy: Expert Review.1 passage
• AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary.1 passage
• AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.1 passage
• AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies: Expert Review.1 passage
• AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review.1 passage
• AGA Clinical Practice Update: Coagulation in Cirrhosis.1 passage
• AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.1 passage
• AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update.1 passage
• AGA Technical Review on Intragastric Balloons in the Management of Obesity.1 passage
• AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).1 passage
• AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.1 passage
• AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.1 passage
• AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.1 passage
• AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53.1 passage
• ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.1 passage
• Abdominal Compression by Waist Belt Aggravates Gastroesophageal Reflux, Primarily by Impairing Esophageal Clearance.1 passage
• Abdominothoracic mechanisms of functional abdominal distension and correction by biofeedback.1 passage
• Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease.1 passage
• Abnormal Responses to Local Esophageal Food Allergen Injections in Adult Patients With Eosinophilic Esophagitis.1 passage
• Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease.1 passage
• Abnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia.1 passage
• Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases.1 passage
• Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.1 passage
• Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.1 passage
• Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population.1 passage
• Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.1 passage
• Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.1 passage
• Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps.1 passage
• Accurate Classification of Diminutive Colorectal Polyps Using Computer-Aided Analysis.1 passage
• Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.1 passage
• Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound Catenacci32 passages
• Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.1 passage
• Activated ATF6 Induces Intestinal Dysbiosis and Innate Immune Response to Promote Colorectal Tumorigenesis.1 passage
• Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.1 passage
• Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells Upon Endoplasmic Reticulum Stress.1 passage
• Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.1 passage
• Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.1 passage
• Activation of Hedgehog Signaling Promotes Development of Mouse and Human Enteric Neural Crest Cells, Based on Single-Cell Transcriptome Analyses.1 passage
• Activation of Nuclear Factor-κB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.1 passage
• Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.1 passage
• Activation of Wnt Signaling Increases Numbers of Enteric Neurons Derived From Neonatal Mouse and Human Progenitor Cells.1 passage
• Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.1 passage
• Active Choice and Financial Incentives to Increase Rates of Screening Colonoscopy-A Randomized Controlled Trial.1 passage
• Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.1 passage
• Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.1 passage
• Acute Pancreatitis and Pancreatic Cancer Risk: A Nationwide Matched-Cohort Study in Denmark.1 passage
• Acute Pancreatitis: A Multifaceted Set of Organelle and Cellular Interactions.1 passage
• Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis.1 passage
• Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.1 passage
• Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.1 passage
• Administration of Antibiotics to Children Before Age 2 Years Increases Risk for Childhood Obesity.1 passage
• Adolescent Obesity and Insulin Resistance: Roles of Ectopic Fat Accumulation and Adipose Inflammation.1 passage
• Advances and Challenges in Endoscopic Training.1 passage
• Advances in CRC Prevention: Screening and Surveillance.1 passage
• Advances in Evaluation of Chronic Diarrhea in Infants.1 passage
• Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.1 passage
• Advances in diagnosis and management of celiac disease.1 passage
• Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.1 passage
• Aging, Frailty, and the Microbiome-How Dysbiosis Influences Human Aging and Disease.1 passage
• Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.1 passage
• Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic Steatohepatitis.1 passage
• Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis.1 passage
• Alcohol Consumption and Multiple Dysplastic Lesions Increase Risk of Squamous Cell Carcinoma in the Esophagus, Head, and Neck.1 passage
• Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Alcohol disrupts levels and function of the cystic fibrosis transmembrane conductance regulator to promote development of pancreatitis.1 passage
• Alcoholic Liver Disease in Asia, Europe, and North America.1 passage
• Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.1 passage
• Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.1 passage
• Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.1 passage
• Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.1 passage
• Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.1 passage
• Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.1 passage
• Alterations in Intestinal Microbiota of Children With Celiac Disease at the Time of Diagnosis and on a Gluten-free Diet.1 passage
• Altered Gut Archaea Composition and Interaction With Bacteria Are Associated With Colorectal Cancer.1 passage
• Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.1 passage
• Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease.1 passage
• Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.1 passage
• Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.1 passage
• American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.1 passage
• American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection.1 passage
• American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions: Clinical Decision Support Tool.1 passage
• American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.1 passage
• American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.1 passage
• Amino Acid Substitutions in Genotype 3a47 passages
• Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir.1 passage
• An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling.1 passage
• An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.1 passage
• An Endoscopic Transluminal Approach, Compared With Minimally Invasive Surgery, Reduces Complications and Costs for Patients With Necrotizing Pancreatitis.1 passage
• An Enhancer-Driven Stem Cell-Like Program Mediated by SOX9 Blocks Intestinal Differentiation in Colorectal Cancer.1 passage
• An Episode Payment Framework for Gastroesophageal Reflux Disease: Symptomatic Gastroesophageal Reflux Disease, Dysplastic and Nondysplastic Barrett's Esophagus, and Anti-Reflux Surgical and Endoscopic Interventions.1 passage
• An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers.1 passage
• An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents.1 passage
• An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.1 passage
• An Interactive Web-Based Educational Tool Improves Detection and Delineation of Barrett's Esophagus-Related Neoplasia.1 passage
• An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.1 passage
• An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis.1 passage
• An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.1 passage
• An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer.1 passage
• An integrated taxonomy for monogenic inflammatory bowel disease.1 passage
• Analysis of Genes Associated With Monogenic Primary Immunodeficiency Identifies Rare Variants in XIAP in Patients With Crohn's Disease.1 passage
• Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.1 passage
• Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response.1 passage
• Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.1 passage
• Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy Individuals.1 passage
• Analysis of dysplasia in patients with Barrett's esophagus based on expression pattern of 90 genes.1 passage
• Analytical Mistakes Confound Attempted Validation: A Response to "Transcription and DNA Methylation Patterns of Blood-Derived CD8+ T Cells Are Associated With Age and Inflammatory Bowel Disease But Do Not Predict Prognosis".1 passage
• Anesthesia Assistance in Outpatient Colonoscopy and Risk of Aspiration Pneumonia, Bowel Perforation, and Splenic Injury.1 passage
• Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.1 passage
• Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.1 passage
• Antibiotic Prophylaxis Is Not Required for Endoscopic Ultrasonography-Guided Fine-Needle Aspiration of Pancreatic Cystic Lesions, Based on a Randomized Trial.1 passage
• Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.1 passage
• Antibody Responses to Immunization With HCV Envelope Glycoproteins as a Baseline for B-Cell-Based Vaccine Development.1 passage
• Antigen-Specific Mucosal Immunity Regulates Development of Intestinal Bacteria-Mediated Diseases.1 passage
• Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection.1 passage
• Anxiety Is Linked to New-Onset Dyspepsia in the Swedish Population: A 10-Year Follow-up Study.1 passage
• Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.1 passage
• Application of Artificial Intelligence to Gastroenterology and Hepatology.1 passage
• Approach to the Management of Recently Diagnosed Inflammatory Bowel Disease Patients: A User's Guide for Adult and Pediatric Gastroenterologists.1 passage
• Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis.1 passage
• Approaches to Integrating Biomarkers Into Clinical Trials and Care Pathways as Targets for the Treatment of Inflammatory Bowel Diseases.1 passage
• Approaches, Progress, and Challenges to37 passages
• Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.1 passage
• Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders.1 passage
• Artificial Intelligence System to Determine Risk of T1 Colorectal Cancer Metastasis to Lymph Node.1 passage
• Aryl Hydrocarbon Receptor Ligands in Cigarette Smoke Induce Production of Interleukin-22 to Promote Pancreatic Fibrosis in Models of Chronic Pancreatitis.1 passage
• Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.1 passage
• Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial.1 passage
• Assessing Old and New Diagnostic Tests for Gastroesophageal Reflux Disease.1 passage
• Association Between Antibiotics in the First Year of Life and Celiac Disease.1 passage
• Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.1 passage
• Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.1 passage
• Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.1 passage
• Association Between Expression Level of PD1 by Tumor-Infiltrating CD81 passage
• Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.1 passage
• Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.1 passage
• Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis.1 passage
• Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.1 passage
• Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein-Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma.1 passage
• Association Between Inflammatory Bowel Diseases and Celiac Disease: A Systematic Review and Meta-Analysis.1 passage
• Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.1 passage
• Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study.1 passage
• Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.1 passage
• Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.1 passage
• Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.1 passage
• Association Between Obesity and Weight Change and Risk of Diverticulitis in Women.1 passage
• Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.1 passage
• Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.1 passage
• Association Between Proton Pump Inhibitor Use and Cognitive Function in Women.1 passage
• Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.1 passage
• Association Between Psychological Distress and Liver Disease Mortality: A Meta-analysis of Individual Study Participants.1 passage
• Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.1 passage
• Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas.1 passage
• Association Between Screen-Detected Gallstone Disease and Cancer in a Cohort Study.1 passage
• Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study.1 passage
• Association Between Sulfur-Metabolizing Bacterial Communities in Stool and Risk of Distal Colorectal Cancer in Men.1 passage
• Association between molecular subtypes of colorectal cancer and patient survival.1 passage
• Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.1 passage
• Association of Aflatoxin and Gallbladder Cancer.1 passage
• Association of Aneuploidy and Flat Dysplasia With Development of High-Grade Dysplasia or Colorectal Cancer in Patients With Inflammatory Bowel Disease.1 passage
• Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study.1 passage
• Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.1 passage
• Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.1 passage
• Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.1 passage
• Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.1 passage
• Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.1 passage
• Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.1 passage
• Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.1 passage
• Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients.1 passage
• Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum.1 passage
• Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease.1 passage
• Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice.1 passage
• Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in Apc1 passage
• Autophagy, Inflammation, and Immune Dysfunction in the Pathogenesis of Pancreatitis.1 passage
• Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.1 passage
• Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial.1 passage
• Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice.1 passage
• BCL3 Reduces the Sterile Inflammatory Response in Pancreatic and Biliary Tissues.1 passage
• BMI1 and MEL18 Promote Colitis-Associated Cancer in Mice via REG3B and STAT3.1 passage
• BRCA1-Associated Protein Increases Invasiveness of Esophageal Squamous Cell Carcinoma.1 passage
• Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.1 passage
• Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.1 passage
• Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.1 passage
• Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.1 passage
• Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.1 passage
• Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.1 passage
• Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes.1 passage
• Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome.1 passage
• Best Practice Update: Incorporating Psychogastroenterology Into Management of Digestive Disorders.1 passage
• Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.1 passage
• Biallelic Mismatch Repair Deficiency: Management and Prevention of a Devastating Manifestation of the Lynch Syndrome.1 passage
• Bifidobacteriumbreve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers.1 passage
• Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.1 passage
• Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration.1 passage
• Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis.1 passage
• Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma.1 passage
• Biomarkers of Inflammation in Inflammatory Bowel Disease.1 passage
• Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease.1 passage
• Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.1 passage
• Blaming the Brain for Obesity: Integration of Hedonic and Homeostatic Mechanisms.1 passage
• Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.1 passage
• Blood-Based Liquid Biopsies: A Noninvasive and Cost-Effective Tool for Improved Risk Assessment and Identification of Lymph Node Metastasis in Patients With Submucosal T1 Colorectal Cancer.1 passage
• Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.1 passage
• Bone Morphogenetic Protein Pathway Antagonism by Grem1 Regulates Epithelial Cell Fate in Intestinal Regeneration.1 passage
• Brief ReportGermline Mutation of RPS20, Encoding a Ribosomal Protein, Causes Predisposition to Hereditary Nonpolyposis Colorectal Carcinoma23 passages
• Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities.1 passage
• Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.1 passage
• Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis.1 passage
• Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.1 passage
• Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.1 passage
• Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021.1 passage
• Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.1 passage
• C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.1 passage
• COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism.1 passage
• CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.1 passage
• CRIg1 passage
• CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure.1 passage
• CXCL10 and CCL21 Promote Migration of Pancreatic Cancer Cells Toward Sensory Neurons and Neural Remodeling in Tumors in Mice, Associated With Pain in Patients.1 passage
• CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD41 passage
• Ca1 passage
• Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.1 passage
• CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.1 passage
• Calculating the Starting Age for Screening in Relatives of Patients With Colorectal Cancer Based on Data From Large Nationwide Data Sets.1 passage
• Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.1 passage
• Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines.1 passage
• Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease.1 passage
• Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.1 passage
• Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.1 passage
• Carcinogenesis of Pancreatic Ductal Adenocarcinoma.1 passage
• Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice.1 passage
• Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis.1 passage
• Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.1 passage
• Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.1 passage
• Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.1 passage
• Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond.1 passage
• Central Reading of Ulcerative Colitis Clinical Trial Videos Using Neural Networks.1 passage
• Centre and Department of Pathology and Diagnostics, University of Verona, Verona, Italy4 The Royal38 passages
• Centre, The Institute of Cancer Research, London, UK⁎ Reprint requests Address requests for reprints to:38 passages
• Challenges to liver transplantation and strategies to improve outcomes.1 passage
• Change in Populations of Macrophages Promotes Development of Delayed Gastric Emptying in Mice.1 passage
• Changes in Metabolic Syndrome Status are Associated With Altered Risk of Pancreatic Cancer: A Nationwide Cohort Study.1 passage
• Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?1 passage
• Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.1 passage
• Changes to Pediatric Gastroenterology Practice During the COVID-19 Pandemic and Lessons Learned: An International Survey of Division and Group Heads.1 passage
• Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?1 passage
• Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures.1 passage
• Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.1 passage
• Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.1 passage
• Chemoprevention of Colorectal Cancer.1 passage
• Childhood Development and the Microbiome-The Intestinal Microbiota in Maintenance of Health and Development of Disease During Childhood Development.1 passage
• Cholera Vaccine Use Is Associated With a Reduced Risk of Death in Patients With Colorectal Cancer: A Population-Based Study.1 passage
• Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.1 passage
• Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.1 passage
• Chromosome-associated protein D3 promotes bacterial clearance in human intestinal epithelial cells by repressing expression of amino acid transporters.1 passage
• Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk.1 passage
• Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.1 passage
• Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1.1 passage
• Circadian Clock Control of Liver Metabolic Functions.1 passage
• Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.1 passage
• Circular RNA CircHIPK3 Promotes Homeostasis of the Intestinal Epithelium by Reducing MicroRNA 29b Function.1 passage
• Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.1 passage
• Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.1 passage
• Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.1 passage
• Circulating and Tissue-Resident CD41 passage
• Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation Hegazy62 passages
• Clarifying the Role of Endoscopic Retrograde Cholangiopancreatography in the Treatment of Patients With Pancreatic Fluid Collections.1 passage
• Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Clinical Characteristics, Hospitalization, and Mortality Rates of Coronavirus Disease 2019 Among Liver Transplant Patients in the United States: A Multicenter Research Network Study.1 passage
• Clinical Guide and Update on Porphyrias.1 passage
• Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies.1 passage
• Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.1 passage
• Clinical Practice Guidelines for the Use of Video Capsule Endoscopy.1 passage
• Clinical Practice Update: Expert Review on Endoscopic Bariatric Therapies.1 passage
• Clinical Practice Update: The Use of Per-Oral Endoscopic Myotomy in Achalasia: Expert Review and Best Practice Advice From the AGA Institute.1 passage
• Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn's Disease.1 passage
• Clinical and Immunologic Features of Ultra-Short Celiac Disease.1 passage
• Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.1 passage
• Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.1 passage
• Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning.1 passage
• Clip Closure After Resection of Large Colorectal Lesions With Substantial Risk of Bleeding.1 passage
• Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial.1 passage
• Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.1 passage
• Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.1 passage
• Cognitive Deficit and White Matter Changes in Persons With Celiac Disease: A Population-Based Study.1 passage
• Collaboration, Not Competition: The Role of Magnetic Resonance, Transient Elastography, and Liver Biopsy in the Diagnosis of Nonalcoholic Fatty Liver Disease.1 passage
• Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.1 passage
• Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome.1 passage
• Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.1 passage
• Colonic Motility Is Improved by the Activation of 5-HT1 passage
• Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies.1 passage
• Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.1 passage
• Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.1 passage
• Colorectal Cancer Incidence After Colonoscopy at Ages 45-49 or 50-54 Years.1 passage
• Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.1 passage
• Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial.1 passage
• Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.1 passage
• Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography.1 passage
• Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.1 passage
• Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.1 passage
• Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.1 passage
• Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis.1 passage
• Combinatorial Transcriptional Profiling of Mouse and Human Enteric Neurons Identifies Shared and Disparate Subtypes In Situ.1 passage
• Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.1 passage
• Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development.1 passage
• Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.1 passage
• Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.1 passage
• Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile.1 passage
• Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort.1 passage
• Community-Based Study of Celiac Disease Autoimmunity Progression in Adults.1 passage
• Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.1 passage
• Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.1 passage
• Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.1 passage
• Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.1 passage
• Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis.1 passage
• Comparison of Culture With Antibiogram to Next-Generation Sequencing Using Bacterial Isolates and Formalin-Fixed, Paraffin-Embedded Gastric Biopsies.1 passage
• Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.1 passage
• Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.1 passage
• Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer.1 passage
• Comparison of Underwater vs Conventional Endoscopic Mucosal Resection of Intermediate-Size Colorectal Polyps.1 passage
• Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Competence in Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography, From Training Through Independent Practice.1 passage
• Competency-based education, feedback, and humility.1 passage
• Complementary and Alternative Medicines Used by Patients With Inflammatory Bowel Diseases.1 passage
• Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.1 passage
• Complications of Proton Pump Inhibitor Therapy.1 passage
• Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.1 passage
• Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery.1 passage
• Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.1 passage
• Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease.1 passage
• Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease.1 passage
• Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.1 passage
• Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.1 passage
• Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.1 passage
• Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.1 passage
• Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.1 passage
• Controversies in Endoscopic Eradication Therapy for Barrett's Esophagus.1 passage
• Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.1 passage
• Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma.1 passage
• Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease.1 passage
• Correction of Defective T-Regulatory Cells From Patients With Crohn's Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α.1 passage
• Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.1 passage
• Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial.1 passage
• Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials.1 passage
• Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.1 passage
• Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.1 passage
• Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.1 passage
• Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer.1 passage
• Cost Efficacy of Metal Stents for Palliation of Extrahepatic Bile Duct Obstruction in a Randomized Controlled Trial.1 passage
• Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.1 passage
• Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.1 passage
• Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.1 passage
• Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?1 passage
• County Differences in Liver Mortality in the United States: Impact of Sociodemographics, Disease Risk Factors, and Access to Care.1 passage
• CpG Island Methylation in Sessile Serrated Adenomas Increases With Age, Indicating Lower Risk of Malignancy in Young Patients.1 passage
• Creatine Transporter, Reduced in Colon Tissues From Patients With Inflammatory Bowel Diseases, Regulates Energy Balance in Intestinal Epithelial Cells, Epithelial Integrity, and Barrier Function.1 passage
• Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial.1 passage
• Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.1 passage
• Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer.1 passage
• Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome.1 passage
• Cumulative Evidence That Mesenchymal Stem Cells Promote Healing of Perianal Fistulas of Patients With Crohn's Disease--Going From Bench to Bedside.1 passage
• Current Concepts in Severe Acute and Necrotizing Pancreatitis: An Evidence-Based Approach.1 passage
• Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer.1 passage
• Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations.1 passage
• DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced Metaplasia.1 passage
• DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.1 passage
• DNA Mismatch Repair Deficiency and Immune Checkpoint Inhibitors in Gastrointestinal Cancers.1 passage
• Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.1 passage
• Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection.1 passage
• Deciphering the Molecular Code to Colorectal Liver Metastasis Biology Through Microsatellite Alterations and Allelic Loss: The Good, the Bad, and the Ugly.1 passage
• Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase.1 passage
• Decreased Complexity of Serum N-glycan Structures Associates with Successful Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.1 passage
• Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.1 passage
• Deep Learning Localizes and Identifies Polyps in Real Time With 96% Accuracy in Screening Colonoscopy.1 passage
• Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.1 passage
• Deep-Learning System Detects Neoplasia in Patients With Barrett's Esophagus With Higher Accuracy Than Endoscopists in a Multistep Training and Validation Study With Benchmarking.1 passage
• Defects in 15-HETE Production and Control of Epithelial Permeability by Human Enteric Glial Cells From Patients With Crohn's Disease.1 passage
• Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.1 passage
• Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.1 passage
• Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms.1 passage
• Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome.1 passage
• Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.1 passage
• Design of Treatment Trials for Functional Gastrointestinal Disorders.1 passage
• Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.1 passage
• Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.1 passage
• Detection of Occult Hepatitis C Virus Infection in Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents for Recurrent Infection After Liver Transplantation.1 passage
• Detection of Sessile Serrated Adenomas in the Proximal Colon Using Wide-Field Fluorescence Endoscopy.1 passage
• Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.1 passage
• Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.1 passage
• Development and Validation of Test for "Leaky Gut" Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults.1 passage
• Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts.1 passage
• Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett's Esophagus Using Narrow-Band Imaging.1 passage
• Development and Validation of a Deep Neural Network for Accurate Evaluation of Endoscopic Images From Patients With Ulcerative Colitis.1 passage
• Development and Validation of a Magnetic Resonance Index for Assessing Fistulas in Patients With Crohn's Disease.1 passage
• Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.1 passage
• Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.1 passage
• Development and Validation of a Mucosal Impedance Contour Analysis System to Distinguish Esophageal Disorders.1 passage
• Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn's Disease.1 passage
• Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.1 passage
• Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's Disease.1 passage
• Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease.1 passage
• Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.1 passage
• Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.1 passage
• Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.1 passage
• Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.1 passage
• Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood.1 passage
• Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women.1 passage
• Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.1 passage
• Diagnosis and Treatment of Eosinophilic Esophagitis.1 passage
• Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.1 passage
• Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.1 passage
• Diagnosis, management, and investigational therapies for food allergies.1 passage
• Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.1 passage
• Dicarbonyl Electrophiles Mediate Inflammation-Induced Gastrointestinal Carcinogenesis.1 passage
• Did Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Really Improve the Survival of Patients with Hepatocellular Carcinoma?1 passage
• Diet and upper gastrointestinal malignancies.1 passage
• Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.1 passage
• Diet in the pathogenesis and treatment of inflammatory bowel diseases.1 passage
• Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.1 passage
• Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis.1 passage
• Dietary Patterns After the Weaning and Lactation Period Are Associated With Celiac Disease Autoimmunity in Children.1 passage
• Dietary Patterns and Risk of Colorectal Cancer: Analysis by Tumor Location and Molecular Subtypes.1 passage
• Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.1 passage
• Differences in Colonoscopy Quality Among Facilities: Development of a Post-Colonoscopy Risk-Standardized Rate of Unplanned Hospital Visits.1 passage
• Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.1 passage
• Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.1 passage
• Diminutive Polyps With Advanced Histologic Features Do Not Increase Risk for Metachronous Advanced Colon Neoplasia.1 passage
• Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.1 passage
• Direct Comparison of Diagnostic Performance of 9 Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.1 passage
• Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.1 passage
• Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.1 passage
• Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.1 passage
• Direct-Acting Antiviral Therapy for HCV Infection Is Associated With a Reduced Risk of Cardiovascular Disease Events.1 passage
• Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.1 passage
• Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's Esophagus.1 passage
• Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.1 passage
• Disruption of Epithelial HDAC3 in Intestine Prevents Diet-Induced Obesity in Mice.1 passage
• Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.1 passage
• Dissection of barrier dysfunction in organoid-derived human intestinal epithelia induced by Giardia duodenalis.1 passage
• Distinct Patterns of Somatic Mosaicism in the APC Gene in Neoplasms From Patients With Unexplained Adenomatous Polyposis.1 passage
• Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease.1 passage
• Diversity Within US Gastroenterology Physician Practices: The Pipeline, Cultural Competencies, and Gastroenterology Societies Approaches.1 passage
• Does Colon Polyp Surveillance Improve Patient Outcomes?1 passage
• Does Fatherhood Matter? Preconception Use of Biologics and Immunomodulators by Fathers With Immune-Mediated Diseases and Birth Outcomes of Their Offspring.1 passage
• Doppler Endoscopic Probe Monitoring of Blood Flow Improves Risk Stratification and Outcomes of Patients With Severe Nonvariceal Upper Gastrointestinal Hemorrhage.1 passage
• Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium.1 passage
• Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.1 passage
• Drug Screen Identifies Leflunomide for Treatment of Inflammatory Bowel Disease Caused by TTC7A Deficiency.1 passage
• Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.1 passage
• Dynamic Properties of the Intestinal Ecosystem Call for Combination Therapies, Targeting Inflammation and Microbiota, in Ulcerative Colitis.1 passage
• Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.1 passage
• ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.1 passage
• EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients Srivatsa Sriram 1∗Paul51 passages
• EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.1 passage
• EUS-Guided Methylene Blue Injection to Facilitate Pancreatic Duct Access After Unsuccessful ERCP.1 passage
• EUS-Guided Transluminal Interventions.1 passage
• Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia.1 passage
• Early Detection of Pancreatic Cancer: Opportunities and Challenges.1 passage
• Early Intra-Acinar Events in Pathogenesis of Pancreatitis.1 passage
• Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.1 passage
• Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis.1 passage
• Early-Life Microbial Restitution Reduces Colitis Risk Promoted by Antibiotic-Induced Gut Dysbiosis in Interleukin 101 passage
• Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.1 passage
• Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study.1 passage
• Effect of Sex, Age, and Positivity Threshold on Fecal Immunochemical Test Accuracy: A Systematic Review and Meta-analysis.1 passage
• Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.1 passage
• Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.1 passage
• Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.1 passage
• Effectiveness of Pelvic Physiotherapy in Children With Functional Constipation Compared With Standard Medical Care.1 passage
• Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.1 passage
• Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.1 passage
• Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System.1 passage
• Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality.1 passage
• Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.1 passage
• Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.1 passage
• Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.1 passage
• Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.1 passage
• Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.1 passage
• Effects of Blended (Yellow) vs Forced Coagulation (Blue) Currents on Adverse Events, Complete Resection, or Polyp Recurrence After Polypectomy in a Large Randomized Trial.1 passage
• Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.1 passage
• Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain.1 passage
• Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.1 passage
• Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.1 passage
• Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension.1 passage
• Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.1 passage
• Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.1 passage
• Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.1 passage
• Effects of Intestinal Fungi and Viruses on Immune Responses and Inflammatory Bowel Diseases.1 passage
• Effects of Long-term Norfloxacin Therapy in Patients With Advanced Cirrhosis.1 passage
• Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.1 passage
• Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.1 passage
• Effects of Nutritional Prehabilitation, With and Without Exercise, on Outcomes of Patients Who Undergo Colorectal Surgery: A Systematic Review and Meta-analysis.1 passage
• Effects of Obesity Surgery on Overall and Disease-Specific Mortality in a 5-Country Population-Based Study.1 passage
• Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.1 passage
• Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population.1 passage
• Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders.1 passage
• Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.1 passage
• Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.1 passage
• Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.1 passage
• Effects of Serotonin and Slow-Release 5-Hydroxytryptophan on Gastrointestinal Motility in a Mouse Model of Depression.1 passage
• Effects of Training and Feedback on Accuracy of Predicting Rectosigmoid Neoplastic Lesions and Selection of Surveillance Intervals by Endoscopists Performing Optical Diagnosis of Diminutive Polyps.1 passage
• Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.1 passage
• Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.1 passage
• Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus.1 passage
• Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.1 passage
• Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.1 passage
• Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.1 passage
• Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.1 passage
• Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.1 passage
• Efficacy and Safety of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Bleeding.1 passage
• Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis.1 passage
• Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study.1 passage
• Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.1 passage
• Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis.1 passage
• Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.1 passage
• Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.1 passage
• Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.1 passage
• Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.1 passage
• Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.1 passage
• Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.1 passage
• Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis.1 passage
• Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.1 passage
• Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.1 passage
• Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial.1 passage
• Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.1 passage
• Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.1 passage
• Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.1 passage
• Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.1 passage
• Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.1 passage
• Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.1 passage
• Efficacy of Injection of Freshly Collected Autologous Adipose Tissue Into Perianal Fistulas in Patients With Crohn's Disease.1 passage
• Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.1 passage
• Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: Misleading Ranking Probabilities in Network Meta-analysis.1 passage
• Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection.1 passage
• Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.1 passage
• Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.1 passage
• Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.1 passage
• Efficacy of Per-oral Methylene Blue Formulation for Screening Colonoscopy.1 passage
• Efficacy of Prophylactic Hemoclips in Prevention of Delayed Post-Polypectomy Bleeding in Patients With Large Colonic Polyps.1 passage
• Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial.1 passage
• Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis.1 passage
• Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.1 passage
• Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.1 passage
• Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.1 passage
• Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.1 passage
• Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis.1 passage
• Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.1 passage
• Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection.1 passage
• Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.1 passage
• Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.1 passage
• Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 Infections.1 passage
• Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.1 passage
• Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.1 passage
• Elevated Liver Enzymes, Ferritin, C-reactive Protein, D-dimer, and Age Are Predictive Markers of Outcomes Among African American and Hispanic Patients With Coronavirus Disease 2019.1 passage
• Elucidating the Role of the Interleukin-10 Receptor in Mucosal Inflammation Uncovers a Potential Treatment for Infantile Inflammatory Bowel Disease.1 passage
• Elucidation of Proteus mirabilis as a Key Bacterium in Crohn's Disease Inflammation.1 passage
• Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2.1 passage
• Endoplasmic Reticulum Stress-Induced Upregulation of STARD1 Promotes Acetaminophen-Induced Acute Liver Failure.1 passage
• Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies.1 passage
• Endoscopic Full Thickness Resection.1 passage
• Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.1 passage
• Endoscopic Management of Pancreatobiliary Neoplasms.1 passage
• Endoscopic Management of Transmural Defects, Including Leaks, Perforations, and Fistulae.1 passage
• Endoscopic Myotomy for Foregut Motility Disorders.1 passage
• Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.1 passage
• Endoscopic Screening in Asian Countries Is Associated With Reduced Gastric Cancer Mortality: A Meta-analysis and Systematic Review.1 passage
• Endoscopic Submucosal Dissection in Europe: Results of 1000 Neoplastic Lesions From the German Endoscopic Submucosal Dissection Registry.1 passage
• Endoscopic Submucosal Dissection in North America: A Large Prospective Multicenter Study.1 passage
• Endoscopic Submucosal Dissection: Indications and Application in Western Endoscopy Practice.1 passage
• Endoscopic Ultrasound-guided Fine-needle Biopsy With or Without Rapid On-site Evaluation for Diagnosis of Solid Pancreatic Lesions: A Randomized Controlled Non-Inferiority Trial.1 passage
• Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.1 passage
• Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats.1 passage
• Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.1 passage
• Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p.1 passage
• Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.1 passage
• Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.1 passage
• Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.1 passage
• Epidemiology and Management of Hepatocellular Carcinoma.1 passage
• Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults.1 passage
• Epidemiology and Natural History of Eosinophilic Esophagitis.1 passage
• Epidemiology of Esophageal Squamous Cell Carcinoma.1 passage
• Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma.1 passage
• Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database.1 passage
• Epidemiology, Pathophysiology, and Treatment of Diverticulitis.1 passage
• Epidemiology, Presentation, and Diagnosis of Celiac Disease.1 passage
• Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.1 passage
• Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.1 passage
• Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer.1 passage
• Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation.1 passage
• Epigenome-Wide Association Study Identifies Methylation Sites Associated With Liver Enzymes and Hepatic Steatosis.1 passage
• Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.1 passage
• Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine.1 passage
• Epithelial Indoleamine 2,3-Dioxygenase 1 Modulates Aryl Hydrocarbon Receptor and Notch Signaling to Increase Differentiation of Secretory Cells and Alter Mucus-Associated Microbiota.1 passage
• Epithelial RNase H2 Maintains Genome Integrity and Prevents Intestinal Tumorigenesis in Mice Aden Konrad k.aden@ikmb.uni-kiel.de12∗Bartsch Kareen 3Dahl Joseph 4Reijns64 passages
• Epithelial RNase H2 Maintains Genome Integrity and Prevents Intestinal Tumorigenesis in Mice.1 passage
• Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.1 passage
• Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.1 passage
• Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.1 passage
• Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.1 passage
• Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.1 passage
• Esophageal Hypervigilance and Symptom-Specific Anxiety in Patients with Eosinophilic Esophagitis.1 passage
• Estimation of Absolute Risk of Colorectal Cancer Based on Healthy Lifestyle, Genetic Risk, and Colonoscopy Status in a Population-Based Study.1 passage
• Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.1 passage
• Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.1 passage
• Ethnicity Associations With Food Sensitization Are Mediated by Gut Microbiota Development in the First Year of Life.1 passage
• Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases.1 passage
• Evaluating Responses to Gluten Challenge: A Randomized, Double-Blind, 2-Dose Gluten Challenge Trial.1 passage
• Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.1 passage
• Events Within the First Year of Life, but Not the Neonatal Period, Affect Risk for Later Development of Inflammatory Bowel Diseases.1 passage
• Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.1 passage
• Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.1 passage
• Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).1 passage
• Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.1 passage
• Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer.1 passage
• Exome Sequencing Reveals Germline SMAD9 Mutation That Reduces Phosphatase and Tensin Homolog Expression and Is Associated With Hamartomatous Polyposis and Gastrointestinal Ganglioneuromas.1 passage
• Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.1 passage
• Exome-Wide Association Study of Pancreatic Cancer Risk.1 passage
• Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.1 passage
• Exposing the Achilles Heel of Antibiotic Therapy for Pouchitis Using Microbial Function and Composition.1 passage
• Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.1 passage
• Exposure to Radiocontrast Agents Induces Pancreatic Inflammation by Activation of Nuclear Factor-κB, Calcium Signaling, and Calcineurin.1 passage
• Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.1 passage
• Expression of CCR6 and CXCR6 by Gut-Derived CD41 passage
• Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.1 passage
• Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.1 passage
• Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.1 passage
• Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN.1 passage
• Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.1 passage
• Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.1 passage
• Extrahepatic morbidity and mortality of chronic hepatitis C.1 passage
• Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.1 passage
• Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.1 passage
• Extrinsic Primary Afferent Neurons Link Visceral Pain to Colon Motility Through a Spinal Reflex in Mice.1 passage
• FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.1 passage
• FXR Isoforms Control Different Metabolic Functions in Liver Cells via Binding to Specific DNA Motifs.1 passage
• FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.1 passage
• Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.1 passage
• Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.1 passage
• Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.1 passage
• Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.1 passage
• Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.1 passage
• Factors Associated With Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation: Unanswered Questions.1 passage
• Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.1 passage
• Factors That Contribute to Differences in Survival of Black vs White Patients With Colorectal Cancer.1 passage
• Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.1 passage
• Famotidine Use Is Not Associated With 30-day Mortality: A Coarsened Exact Match Study in 7158 Hospitalized Patients With Coronavirus Disease 2019 From a Large Healthcare System.1 passage
• Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.1 passage
• Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.1 passage
• Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.1 passage
• Features of Patients With Hereditary Mixed Polyposis Syndrome Caused by Duplication of GREM1 and Implications for Screening and Surveillance.1 passage
• Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection.1 passage
• Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.1 passage
• Fecal Microbiota Transplantation Influences Procarcinogenic Escherichia coli in Recipient Recurrent Clostridioides difficile Patients.1 passage
• Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry.1 passage
• Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.1 passage
• Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.1 passage
• Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Associates With Functional Alterations in Circulating microRNAs.1 passage
• Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Enhances Adaptive Immunity to C difficile Toxin B.1 passage
• Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.1 passage
• Fellow Education Improved Through Mobile Clinical Decision Support Application: A Multi-Center Approach Involving Peri-Procedural Antithrombotic Use.1 passage
• Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome.1 passage
• Fermentable Sugar Ingestion, Gas Production, and Gastrointestinal and Central Nervous System Symptoms in Patients With Functional Disorders.1 passage
• Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.1 passage
• Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers.1 passage
• Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.1 passage
• Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells Moran-Salvador Eva ∗Garcia-Macia Marina ∗Sivaharan Ashwin ∗Sabater Laura Zaki46 passages
• Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.1 passage
• Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.1 passage
• Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.1 passage
• Food allergies: the basics.1 passage
• Food components and irritable bowel syndrome.1 passage
• Food, immunity, and the microbiome.1 passage
• Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies.1 passage
• Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.1 passage
• Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis.1 passage
• Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.1 passage
• From Birth to Overweight and Atopic Disease: Multiple and Common Pathways of the Infant Gut Microbiome.1 passage
• From Intention to Action: Operationalizing AGA Diversity Policy to Combat Racism and Health Disparities in Gastroenterology.1 passage
• Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity.1 passage
• Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.1 passage
• Full Report: Basic and Translational—LiverCSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure Stutchfield45 passages
• Full Report: Basic and Translational—LiverIncreased Expression of48 passages
• Full Report: Basic and Translational—LiverSphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis King Andrew andyking@doctors.org.uk1∗Houlihan53 passages
• Full Report: Basic and Translational—PancreasFascin Is Regulated by Slug, Promotes Progression of Pancreatic Cancer in Mice, and Is Associated With Patient Outcomes Li Ang 1Morton57 passages
• Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.1 passage
• Fully Covered Self-Expanding Metal Stent vs Multiple Plastic Stents to Treat Benign Biliary Strictures Secondary to Chronic Pancreatitis: A Multicenter Randomized Trial.1 passage
• Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research.1 passage
• Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.1 passage
• Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?1 passage
• Functional Restoration of Bacteriomes and Viromes by Fecal Microbiota Transplantation.1 passage
• Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.1 passage
• Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.1 passage
• G-Protein-Coupled Receptors Are Dynamic Regulators of Digestion and Targets for Digestive Diseases.1 passage
• GNAS1 passage
• GPR120 Inhibits Colitis Through Regulation of CD41 passage
• GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.1 passage
• GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.1 passage
• Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial.1 passage
• Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease.1 passage
• Gastrin Induces Nuclear Export and Proteasome Degradation of Menin in Enteric Glial Cells.1 passage
• Gastroduodenal Disorders.1 passage
• Gastroenterologist-Level Identification of Small-Bowel Diseases and Normal Variants by Capsule Endoscopy Using a Deep-Learning Model.1 passage
• Gastroenterology682 passages
• Gastrointestinal Autoimmunity Associated With Loss of Central Tolerance to Enteric α-Defensins.1 passage
• Gastrointestinal Complications of Obesity.1 passage
• Gastrointestinal Infection and Risk of Microscopic Colitis: A Nationwide Case-Control Study in Sweden.1 passage
• Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.1 passage
• Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study.1 passage
• Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases.1 passage
• Gastrointestinal and Extra-Intestinal Manifestations of IgG4-Related Disease.1 passage
• Gastroparesis.1 passage
• Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.1 passage
• Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis.1 passage
• Gene Expression Signature in Surgical Tissues and Endoscopic Biopsies Identifies High-Risk T1 Colorectal Cancers.1 passage
• Gene Expression Signatures Associated With Survival Times of Pediatric Patients With Biliary Atresia Identify Potential Therapeutic Agents.1 passage
• Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome.1 passage
• Genesis of Esophageal Pressurization and Bolus Flow Patterns in Patients With Achalasia Esophagus.1 passage
• Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.1 passage
• Genetic Complexity of Crohn's Disease in Two Large Ashkenazi Jewish Families.1 passage
• Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families Levine40 passages
• Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.1 passage
• Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.1 passage
• Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease.1 passage
• Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression.1 passage
• Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases.1 passage
• Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.1 passage
• Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.1 passage
• Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.1 passage
• Genetic Risk Score Is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer Screening Population.1 passage
• Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.1 passage
• Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.1 passage
• Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.1 passage
• Genetics and Genetic Testing in Hereditary Colorectal Cancer.1 passage
• Genetics and Genetic Testing in Pancreatic Cancer.1 passage
• Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma.1 passage
• Genetics of Familial and Sporadic Pancreatic Cancer.1 passage
• Genetics of Inflammatory Bowel Diseases.1 passage
• Genetics, Cell Biology, and Pathophysiology of Pancreatitis.1 passage
• Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin.1 passage
• Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection.1 passage
• Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.1 passage
• Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.1 passage
• Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.1 passage
• Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.1 passage
• Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.1 passage
• Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma.1 passage
• Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population.1 passage
• Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.1 passage
• Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.1 passage
• Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.2 passages
• Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.1 passage
• Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.1 passage
• Germline Genetic Features of Young Individuals With Colorectal Cancer.1 passage
• Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer.1 passage
• Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.1 passage
• Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.1 passage
• Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.1 passage
• Glial Cell-Derived Neurotrophic Factor Induces Enteric Neurogenesis and Improves Colon Structure and Function in Mouse Models of Hirschsprung Disease.1 passage
• Global Burden of 5 Major Types of Gastrointestinal Cancer.1 passage
• Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis.1 passage
• Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.1 passage
• Global prevalence and impact of Rumination syndrome.1 passage
• Glucocorticoids and Androgens Protect From Gastric Metaplasia by Suppressing Group 2 Innate Lymphoid Cell Activation.1 passage
• Glucose-Dependent Insulinotropic Peptide Stimulates Glucagon-Like Peptide 1 Production by Pancreatic Islets via Interleukin 6, Produced by α Cells.1 passage
• Gluten Degradation, Pharmacokinetics, Safety, and Tolerability of TAK-062, an Engineered Enzyme to Treat Celiac Disease.1 passage
• Glycome Patterns of Perfusate in Livers Before Transplantation Associate With Primary Nonfunction.1 passage
• Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.1 passage
• Group 2 Innate Lymphoid Cells Coordinate Damage Response in the Stomach.1 passage
• Group, Szeged, Hungary∗ Reprint requests Address requests for reprints to: Julia Mayerle, MD, Department of46 passages
• Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review.1 passage
• Gut-liver axis in alcoholic liver disease.1 passage
• HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.1 passage
• HBV DNA Integration and Clonal Hepatocyte Expansion in Chronic Hepatitis B Patients Considered Immune Tolerant.1 passage
• HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.1 passage
• HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.1 passage
• HIF1-alpha Regulates Acinar Cell Function and Response to Injury in Mouse Pancreas.1 passage
• HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability.1 passage
• HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.1 passage
• HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.1 passage
• Hdac1 Regulates Differentiation of Bipotent Liver Progenitor Cells During Regeneration via Sox9b and Cdk8.1 passage
• Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients.1 passage
• Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk.1 passage
• Hedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells.1 passage
• Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.1 passage
• Helicobacter pylori Activates and Expands Lgr5(+) Stem Cells Through Direct Colonization of the Gastric Glands.1 passage
• Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.1 passage
• Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.1 passage
• Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.1 passage
• Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.1 passage
• Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.1 passage
• Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.1 passage
• Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.1 passage
• Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.1 passage
• Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.1 passage
• Hepatitis C Virus RNA Persists in Liver Explants of Most Patients Awaiting Liver Transplantation Treated With an Interferon-Free Regimen.1 passage
• Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.1 passage
• Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication.1 passage
• Hepatitis D Virus-Specific CD81 passage
• Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.1 passage
• Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.1 passage
• Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.1 passage
• Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.1 passage
• Herbal products and the liver: a review of adverse effects and mechanisms.1 passage
• Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.1 passage
• Heterotrimeric G Stimulatory Protein α Subunit Is Required for Intestinal Smooth Muscle Contraction in Mice.1 passage
• Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans.1 passage
• High Efficacy of ABT-493 and ABT-530 Treatment in Patients With HCV Genotype 1 or 3 Infection and Compensated Cirrhosis.1 passage
• High Incidence of Celiac Disease in a Long-term Study of Adolescents With Susceptibility Genotypes.1 passage
• High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.1 passage
• High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.1 passage
• High Proportions of People With Nonceliac Wheat Sensitivity Have Autoimmune Disease or Antinuclear Antibodies.1 passage
• High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.1 passage
• High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.1 passage
• High-Fat Diet Promotes Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites.1 passage
• High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.1 passage
• High-Quality Diets Associate With Reduced Risk of Colorectal Cancer: Analyses of Diet Quality Indexes in the Multiethnic Cohort.1 passage
• High-Throughput Screen Identifies Host and Microbiota Regulators of Intestinal Barrier Function.1 passage
• Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.1 passage
• Highly Multiplexed Image Analysis of Intestinal Tissue Sections in Patients With Inflammatory Bowel Disease.1 passage
• Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.1 passage
• Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.1 passage
• Histologic Factors Associated With Need for Surgery in Patients With Pedunculated T1 Colorectal Carcinomas.1 passage
• Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY).1 passage
• Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.1 passage
• Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis.1 passage
• Host-Microbiota Interactions in the Esophagus During Homeostasis and Allergic Inflammation.1 passage
• How to Create an Unfunded Teaching Fellowship During the Gastroenterology Fellowship That Positively Impacts Subsequent Teaching Activities and Career Path.1 passage
• Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.1 passage
• Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology.1 passage
• Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.1 passage
• Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses.1 passage
• Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface.1 passage
• Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease.1 passage
• Hyperglycemia Increases Interstitial Cells of Cajal via MAPK1 and MAPK3 Signaling to ETV1 and KIT, Leading to Rapid Gastric Emptying.1 passage
• Hypermutation In Pancreatic Cancer.1 passage
• IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.1 passage
• IL1B Increases Intestinal Tight Junction Permeability by Up-regulation of MIR200C-3p, Which Degrades Occludin mRNA.1 passage
• IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans.1 passage
• IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial.1 passage
• Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.1 passage
• Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease.1 passage
• Identification of Extracolonic Pathologies by Computed Tomographic Colonography in Colorectal Cancer Symptomatic Patients.1 passage
• Identification of GLI Mutations in Patients With Hirschsprung Disease That Disrupt Enteric Nervous System Development in Mice.1 passage
• Identification of Genes Associated With Hirschsprung Disease, Based on Whole-Genome Sequence Analysis, and Potential Effects on Enteric Nervous System Development.1 passage
• Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.1 passage
• Identification of Loci at 1q21 and 16q23 That Affect Susceptibility to Inflammatory Bowel Disease in Koreans.1 passage
• Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.1 passage
• Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.1 passage
• Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.1 passage
• Identification of Stem Cells in the Epithelium of the Stomach Corpus and Antrum of Mice.1 passage
• Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.1 passage
• Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.1 passage
• Identification of Variants in RET and IHH Pathway Members in a Large Family With History of Hirschsprung Disease.1 passage
• Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.1 passage
• Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21.1 passage
• Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis.1 passage
• Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.1 passage
• Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.1 passage
• Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study.1 passage
• Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects.1 passage
• Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.1 passage
• Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.1 passage
• Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.1 passage
• Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma.1 passage
• Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts.1 passage
• Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis.1 passage
• Impaired Exocrine Pancreatic Function Associates With Changes in Intestinal Microbiota Composition and Diversity.1 passage
• Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.1 passage
• Impaired Redox and Protein Homeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia.1 passage
• Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.1 passage
• Impaired upper esophageal sphincter reflexes in patients with supraesophageal reflux disease.1 passage
• Improved Accuracy in Optical Diagnosis of Colorectal Polyps Using Convolutional Neural Networks with Visual Explanations.1 passage
• Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.1 passage
• Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.1 passage
• In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.1 passage
• In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.1 passage
• In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.1 passage
• In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.1 passage
• In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of46 passages
• In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.1 passage
• In Vivo Imaging Reveals Existence of Crypt Fission and Fusion in Adult Mouse Intestine Bruens Lotte 123Ellenbroek15 passages
• In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection.1 passage
• Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.1 passage
• Incidence and Mortality in Upper Gastrointestinal Cancer After Negative Endoscopy for Gastroesophageal Reflux Disease.1 passage
• Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.1 passage
• Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer.1 passage
• Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus.1 passage
• Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.1 passage
• Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.1 passage
• Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.1 passage
• Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.1 passage
• Incidence, Risk Factors, and Clinical Effects of Recurrent Diverticular Hemorrhage: A Large Cohort Study.1 passage
• Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.1 passage
• Increased Expression of DUOX2 Is an Epithelial Response to Mucosal Dysbiosis Required for Immune Homeostasis in Mouse Intestine.1 passage
• Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.1 passage
• Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.1 passage
• Increased Long-term Dietary Fiber Intake Is Associated With a Decreased Risk of Fecal Incontinence in Older Women.1 passage
• Increased Mortality of Patients With Childhood-Onset Inflammatory Bowel Diseases, Compared With the General Population.1 passage
• Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.1 passage
• Increased Rate of Adenoma Detection Associates With Reduced Risk of Colorectal Cancer and Death.1 passage
• Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.1 passage
• Increased Risk of Colorectal Cancer Development Among Patients With Serrated Polyps.1 passage
• Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps.1 passage
• Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.1 passage
• Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.1 passage
• Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.1 passage
• Increased risk of functional gastrointestinal sequelae after Clostridium difficile infection among active duty United States military personnel (1998-2010).1 passage
• Increasing Health Care Burden of Chronic Liver Disease Compared With Other Chronic Diseases, 2004-2013.1 passage
• Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.1 passage
• Increasing Rates of Surgery for Patients With Nonmalignant Colorectal Polyps in the United States.1 passage
• Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.1 passage
• Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study.1 passage
• Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity.1 passage
• Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.1 passage
• Infected Necrotizing Pancreatitis: Evolving Interventional Strategies From Minimally Invasive Surgery to Endoscopic Therapy-Evidence Mounts, But One Size Does Not Fit All.1 passage
• Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.1 passage
• Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.1 passage
• Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair.1 passage
• Inflammation-Induced Expression and Secretion of MicroRNA 122 Leads to Reduced Blood Levels of Kidney-Derived Erythropoietin and Anemia.1 passage
• Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.1 passage
• Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group.1 passage
• Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.1 passage
• Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.1 passage
• Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.1 passage
• Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies.1 passage
• Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.1 passage
• Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer.1 passage
• Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.1 passage
• Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.1 passage
• Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.1 passage
• Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.1 passage
• Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.1 passage
• Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.1 passage
• Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.1 passage
• Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.1 passage
• Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models.1 passage
• Initial Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 112 Patients From Veracruz in Southeastern Mexico.1 passage
• Innate Immune Cell Trafficking and Function During Sterile Inflammation of the Liver.1 passage
• Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue.1 passage
• Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.1 passage
• Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.1 passage
• Insights Into the Pathophysiology of Esophageal Adenocarcinoma.1 passage
• Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis.1 passage
• Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis.1 passage
• Integrative analysis of the Inflammatory Bowel Disease serum metabolome improves our understanding of genetic etiology and points to novel putative therapeutic targets.1 passage
• Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.1 passage
• Intensive Lifestyle Intervention for Obesity: Principles, Practices, and Results.1 passage
• Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.1 passage
• Interferon Lambda Promotes Paneth Cell Death Via STAT1 Signaling in Mice and Is Increased in Inflamed Ileal Tissues of Patients With Crohn's Disease.1 passage
• Interferon-Gamma-Producing CD81 passage
• Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.1 passage
• Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.1 passage
• Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor-Dependent Serrated Polyps in Mouse Cecum.1 passage
• Interleukin 17, Produced by γδ T Cells, Contributes to Hepatic Inflammation in a Mouse Model of Biliary Atresia and Is Increased in Livers of Patients.1 passage
• Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.1 passage
• Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.1 passage
• Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.1 passage
• Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.1 passage
• Interleukin 6 alters localization of hMSH3, leading to DNA mismatch repair defects in colorectal cancer cells.1 passage
• Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.1 passage
• Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.1 passage
• Intestinal Bacteria Maintain Adult Enteric Nervous System and Nitrergic Neurons via Toll-like Receptor 2-induced Neurogenesis in Mice.1 passage
• Intestinal Dysbiosis Featuring Abundance of Ruminococcus gnavus Associates With Allergic Diseases in Infants.1 passage
• Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota.1 passage
• Intestinal Epithelial TBK1 Prevents Differentiation of T-helper 17 Cells and Tumorigenesis in Mice.1 passage
• Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency van Rijn68 passages
• Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency.1 passage
• Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.1 passage
• Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.1 passage
• Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related Disease.1 passage
• Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.1 passage
• Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis.1 passage
• Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.1 passage
• Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.1 passage
• Intraductal Papillary Mucinous Neoplasms Arise From Multiple Independent Clones, Each With Distinct Mutations.1 passage
• Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical Review.1 passage
• Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?1 passage
• Is Tenofovir Associated with a Lower Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Compared With Entecavir?1 passage
• Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues.1 passage
• Is There an Optimal Diet for Weight Management and Metabolic Health?1 passage
• Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.1 passage
• Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.1 passage
• JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.1 passage
• JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.1 passage
• KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers.1 passage
• Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration.1 passage
• Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.1 passage
• Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.1 passage
• Lack of Survival Benefit Following Liver Transplantation With MELD Exception Points for Hepatocellular Carcinoma: Beyond the Unblinding of Lady Justice.1 passage
• Lactobacilli Degrade Wheat Amylase Trypsin Inhibitors to Reduce Intestinal Dysfunction Induced by Immunogenic Wheat Proteins.1 passage
• Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.1 passage
• Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice.1 passage
• Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.1 passage
• Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.1 passage
• Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.1 passage
• Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for Colorectal Cancer.1 passage
• Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.1 passage
• Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.1 passage
• Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.1 passage
• Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.1 passage
• Less Is More: A Minimalist Approach to Endoscopy.1 passage
• Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.1 passage
• Letter to the Editor in Response to "Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer".1 passage
• Letter to the Editor: Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: A Meta-analysis of Individual Patient Data.1 passage
• Leukocyte Trafficking to the Small Intestine and Colon.1 passage
• Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals.1 passage
• Lifestyle Risk Factors for Serrated Colorectal Polyps: A Systematic Review and Meta-analysis.1 passage
• Linking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes.1 passage
• Linking Strain Engraftment in Fecal Microbiota Transplantation With Maintenance of Remission in Crohn's Disease.1 passage
• Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.1 passage
• Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.1 passage
• Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation.1 passage
• Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.1 passage
• Liver Stem Cells: Experimental Findings and Implications for Human Liver Disease.1 passage
• Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.1 passage
• Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.1 passage
• Liver-Resident Bystander CD81 passage
• Liver-specific deletion of augmenter of liver regeneration accelerates development of steatohepatitis and hepatocellular carcinoma in mice.1 passage
• Local communication among mucosal immune cells in patients with celiac disease.1 passage
• Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.1 passage
• Long Noncoding RNA uc.173 Promotes Renewal of the Intestinal Mucosa by Inducing Degradation of MicroRNA 195.1 passage
• Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma.1 passage
• Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.1 passage
• Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.1 passage
• Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.1 passage
• Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.1 passage
• Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population.1 passage
• Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.1 passage
• Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.1 passage
• Long-term Safety and Efficacy of Local Microinjection Combining Autologous Microfat and Adipose-Derived Stromal Vascular Fraction for the Treatment of Refractory Perianal Fistula in Crohn's Disease.1 passage
• Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.1 passage
• Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy.1 passage
• Longer Withdrawal Time Is Associated With a Reduced Incidence of Interval Cancer After Screening Colonoscopy.1 passage
• Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies.1 passage
• Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.1 passage
• Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.1 passage
• Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.1 passage
• Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.1 passage
• Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.1 passage
• Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis.1 passage
• Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting.1 passage
• Loss of MYO5B Leads to Reductions in Na1 passage
• Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.1 passage
• Loss of Pten and Activation of Kras Synergistically Induce Formation of Intraductal Papillary Mucinous Neoplasia From Pancreatic Ductal Cells in Mice.1 passage
• Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.1 passage
• Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.1 passage
• Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study.1 passage
• Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.1 passage
• Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial.1 passage
• Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer.1 passage
• Lower Adenoma Miss Rate of Computer-Aided Detection-Assisted Colonoscopy vs Routine White-Light Colonoscopy in a Prospective Tandem Study.1 passage
• Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States.1 passage
• Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated with Anti-TNFα.1 passage
• MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.1 passage
• MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.1 passage
• MCL1 Is Required for Maintenance of Intestinal Homeostasis and Prevention of Carcinogenesis in Mice.1 passage
• MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.1 passage
• MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice.1 passage
• MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.1 passage
• MIRROR MIRROR ON THE WALL, WHO IS THE FITTEST OF THEM ALL: A NOVEL PREDICTION MODEL FOR POSTOPERATIVE HEPATIC DECOMPENSATION IN PATIENTS WITH CIRRHOSIS.1 passage
• Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.1 passage
• Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.1 passage
• Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.1 passage
• Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.1 passage
• Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma.1 passage
• Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells.1 passage
• Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases.1 passage
• Management of Gastroesophageal Reflux Disease.1 passage
• Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus.1 passage
• Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting.1 passage
• Many Patients With Irritable Bowel Syndrome Have Atypical Food Allergies Not Associated With Immunoglobulin E.1 passage
• Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus.1 passage
• Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.1 passage
• Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs.1 passage
• Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.1 passage
• Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.1 passage
• Mechanisms, Evaluation, and Management of Chronic Constipation.1 passage
• Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.1 passage
• Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.1 passage
• Mesenchymal Cells in Colon Cancer.1 passage
• Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues.1 passage
• Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.1 passage
• Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?1 passage
• Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.1 passage
• Metabolic and Bariatric Surgery for Obesity.1 passage
• Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health-Pathophysiology and Therapeutic Strategies.1 passage
• Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.1 passage
• Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.1 passage
• Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.1 passage
• Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.1 passage
• Methotrexate Reduces DNA Integrity in Sperm From Men With Inflammatory Bowel Disease.1 passage
• Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome.1 passage
• Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.1 passage
• Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.1 passage
• MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.1 passage
• MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.1 passage
• MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.1 passage
• MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.1 passage
• MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells.1 passage
• MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice.1 passage
• MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.1 passage
• MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors.1 passage
• Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.1 passage
• Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.1 passage
• Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.1 passage
• Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.1 passage
• Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.1 passage
• Misoprostol Heals Small Bowel Ulcers in Aspirin Users With Small Bowel Bleeding.1 passage
• Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.1 passage
• Mitochondrial Dysfunction, Through Impaired Autophagy, Leads to Endoplasmic Reticulum Stress, Deregulated Lipid Metabolism, and Pancreatitis in Animal Models.1 passage
• Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis.1 passage
• Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.1 passage
• Model to Select On-Therapy vs Off-Therapy Tests for Patients With Refractory Esophageal or Extraesophageal Symptoms.1 passage
• Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids.1 passage
• Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death.1 passage
• Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2.1 passage
• Molecular Characterization of Limited Ulcerative Colitis Reveals Novel Biology and Predictors of Disease Extension.1 passage
• Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.1 passage
• Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.1 passage
• Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome.1 passage
• Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.1 passage
• MondoA-Thioredoxin-Interacting Protein Axis Maintains Regulatory T-Cell Identity and Function in Colorectal Cancer Microenvironment.1 passage
• Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.1 passage
• Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study.1 passage
• Most Patients Are Willing to Undergo Elective Endoscopic Procedures During the Reopening Period of the Coronavirus 2019 Pandemic.1 passage
• Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.1 passage
• Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations Andersson44 passages
• Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.1 passage
• Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations Seidlitz Therese 1Chen Yi-Ting 23Uhlemann Heike 1Schölch Sebastian 145Kochall Susan 1Merker42 passages
• Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.1 passage
• Mouse and Human Liver Contain Immunoglobulin A-Secreting Cells Originating From Peyer's Patches and Directed Against Intestinal Antigens.1 passage
• Mucin 5AC Serves as the Nexus for β-Catenin/c-Myc Interplay to Promote Glutamine Dependency During Pancreatic Cancer Chemoresistance.1 passage
• Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis.1 passage
• Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.1 passage
• Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction.1 passage
• Mucosal impedance discriminates GERD from non-GERD conditions.1 passage
• Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.1 passage
• Multi-Omics Analyses Show Disease, Diet, and Transcriptome Interactions With the Virome.1 passage
• Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.1 passage
• Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.1 passage
• Mutations in Hepatitis D Virus Allow It to Escape Detection by CD81 passage
• Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level Karimzadeh Hadi 1220∗Kiraithe34 passages
• Mutations in Mitochondrial DNA From Pancreatic Ductal Adenocarcinomas Associate With Survival Times of Patients and Accumulate as Tumors Progress.1 passage
• Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction.1 passage
• Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.1 passage
• NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.1 passage
• NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.1 passage
• NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis.1 passage
• Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice Li Guangfu 123*Liu Dai 12*Kimchi36 passages
• Narrow-Band Imaging for Detection of Neoplasia at Colonoscopy: A Meta-analysis of Data From Individual Patients in Randomized Controlled Trials.1 passage
• Nationwide Trends in Acute and Chronic Pancreatitis Among Privately Insured Children and Non-Elderly Adults in the United States, 2007-2014.1 passage
• Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome.1 passage
• Neural responses to macronutrients: hedonic and homeostatic mechanisms.1 passage
• Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.1 passage
• Neuronal Development and Onset of Electrical Activity in the Human Enteric Nervous System.1 passage
• Neuronal Transforming Growth Factor beta Signaling via SMAD3 Contributes to Pain in Animal Models of Chronic Pancreatitis.1 passage
• Neutrophil Extracellular Traps Induce Trypsin Activation, Inflammation, and Tissue Damage in Mice With Severe Acute Pancreatitis.1 passage
• Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer.1 passage
• New Developments in Managing Variceal Bleeding.1 passage
• New Genetic and Genomic Approaches After the Genome-wide Association Study Era--Back to the Future.1 passage
• New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.1 passage
• New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting.1 passage
• New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.1 passage
• New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies.1 passage
• No Association Between CEL-HYB Hybrid Allele and Chronic Pancreatitis in Asian Populations.1 passage
• No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.1 passage
• No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.1 passage
• No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.1 passage
• No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.1 passage
• No Excess Cancer Recurrence After Immunosuppressive Drugs in a Meta-analysis of Cohorts of Patients With Immune-mediated Diseases: A Mirage Related to Propensity Bias?1 passage
• No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).1 passage
• No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication.1 passage
• No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis.1 passage
• Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.1 passage
• Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.1 passage
• Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?1 passage
• Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.1 passage
• Nonceliac gluten sensitivity.1 passage
• Nonfood Prebiotic, Probiotic, and Synbiotic Use Has Increased in US Adults and Children From 1999 to 2018.1 passage
• Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.1 passage
• Notch Signaling Mediates Differentiation in Barrett's Esophagus and Promotes Progression to Adenocarcinoma.1 passage
• Novel Circulating and Tissue Monocytes as Well as Macrophages in Pancreatitis and Recovery.1 passage
• Novel Developments in Endoscopic Mucosal Imaging.1 passage
• Novel Fecal Biomarkers That Precede Clinical Diagnosis of Ulcerative Colitis.1 passage
• Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.1 passage
• Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.1 passage
• Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.1 passage
• Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening.1 passage
• Nutrients, foods, and colorectal cancer prevention.1 passage
• Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells.1 passage
• OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.1 passage
• Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.1 passage
• Obesity Energetics: Body Weight Regulation and the Effects of Diet Composition.1 passage
• Off-therapy response after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B: An international, multi-center, multi-ethnic cohort (RETRACT-B study).1 passage
• Older Age Reduces Upper Esophageal Sphincter and Esophageal Body Responses to Simulated Slow and Ultraslow Reflux Events and Post-Reflux Residue.1 passage
• Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.1 passage
• Opportunities and Challenges for Pancreatic Circulating Tumor Cells.1 passage
• Optimizing the Quality of Colorectal Cancer Screening Worldwide.1 passage
• Organ Failure Due to Systemic Injury in Acute Pancreatitis.1 passage
• Organoid Models of Human Gastrointestinal Development and Disease.1 passage
• Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis.1 passage
• Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.1 passage
• Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.1 passage
• Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection.1 passage
• Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study.1 passage
• Outcomes of Pregnant Women With Cirrhosis and Their Infants in a Population-Based Study.1 passage
• Outcomes of SARS-CoV-2 Infection in Patients With Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study.1 passage
• Outcomes of Thermal Ablation of the Mucosal Defect Margin After Endoscopic Mucosal Resection: A Prospective, International, Multicenter Trial of 1000 Large Nonpedunculated Colorectal Polyps.1 passage
• Over-the-Scope Clips Are More Effective Than Standard Endoscopic Therapy for Patients With Recurrent Bleeding of Peptic Ulcers.1 passage
• Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.1 passage
• P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.1 passage
• PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice.1 passage
• PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis.1 passage
• PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.1 passage
• Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems.1 passage
• Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.1 passage
• Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.1 passage
• Pancreatitis in Children.1 passage
• Pancreatitis-Induced Depletion of Syntaxin 2 Promotes Autophagy and Increases Basolateral Exocytosis.1 passage
• Paneth Cell Alertness to Pathogens Maintained by Vitamin D Receptors.1 passage
• Paneth Cell Alterations in the Development and Phenotype of Crohn's Disease.1 passage
• Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.1 passage
• Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma.1 passage
• Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).1 passage
• Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases.1 passage
• Pathobiology of Helicobacter pylori-Induced Gastric Cancer.1 passage
• Pathogenesis and Cells of Origin of Barrett's Esophagus.1 passage
• Pathogenesis of Nonalcoholic Steatohepatitis.1 passage
• Pathogenesis of and New Therapies for Hepatitis D.1 passage
• Pathophysiology and Biomarker Potential of Fatty Acid Ethyl Ester Elevation During Alcoholic Pancreatitis.1 passage
• Pathophysiology of Eosinophilic Esophagitis.1 passage
• Pathophysiology of Gastroesophageal Reflux Disease.1 passage
• Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea.1 passage
• Pathways of Colorectal Carcinogenesis.1 passage
• Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.1 passage
• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.1 passage
• Patient Electronic Health Records as a Means to Approach Genetic Research in Gastroenterology.1 passage
• Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.1 passage
• Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.1 passage
• Patterns and Trends of Liver Cancer Incidence Rates in Eastern and Southeastern Asian Countries (1983-2007) and Predictions to 2030.1 passage
• Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.1 passage
• Pediatric COVID-19 and Gastrointestinal Symptoms in Africa.1 passage
• Pentoxifylline Treatment in Severe Acute Pancreatitis: A Pilot, Double-Blind, Placebo-Controlled, Randomized Trial.1 passage
• Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.1 passage
• Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.1 passage
• Peripheral mechanisms in appetite regulation.1 passage
• Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial Peritonitis.1 passage
• Persistence of Nonceliac Wheat Sensitivity, Based on Long-term Follow-up.1 passage
• Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.1 passage
• Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice.1 passage
• Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.1 passage
• Perspectives on Treatment for Nonalcoholic Steatohepatitis.1 passage
• Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.1 passage
• Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.1 passage
• Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome.1 passage
• Physician Non-adherence to Colonoscopy Interval Guidelines in the Veterans Affairs Healthcare System.1 passage
• Physiological Mechanisms of Weight Gain-Induced Steatosis in People With Obesity.1 passage
• Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.1 passage
• Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.1 passage
• Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.1 passage
• Plasmid Acquisition Alters Vancomycin Susceptibility in Clostridioides difficile.1 passage
• Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.1 passage
• Polyclonal Crypt Genesis and Development of Familial Small Intestinal Neuroendocrine Tumors.1 passage
• Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.1 passage
• Population Health Management for Inflammatory Bowel Disease.1 passage
• Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older.1 passage
• Population-Level Configurations of Gut Mycobiome Across 6 Ethnicities in Urban and Rural China.1 passage
• Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.1 passage
• Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies.1 passage
• Postprandial Nutrient Handling and Gastrointestinal Hormone Secretion After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy.1 passage
• Potential Impact of Time Trend of Lifestyle Risk Factors on Burden of Major Gastrointestinal Cancers in China.1 passage
• Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.1 passage
• Practical Use of Pharmacotherapy for Obesity.1 passage
• Practice Patterns for Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography for Patients With Choledocholithiasis.1 passage
• Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity.1 passage
• Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.1 passage
• Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program.1 passage
• Predictors of Use of Monitored Anesthesia Care for Outpatient Gastrointestinal Endoscopy in a Capitated Payment System.1 passage
• Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.1 passage
• Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease.1 passage
• Preparing for the NASH Epidemic: A Call to Action.1 passage
• Presentation and Epidemiology of Gastroesophageal Reflux Disease.1 passage
• Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases.1 passage
• Prevalence and Characteristics of Gastrointestinal Symptoms in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States: A Multicenter Cohort Study.1 passage
• Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single Center.1 passage
• Prevalence and Clinical Features of Sessile Serrated Polyps: A Systematic Review.1 passage
• Prevalence and Effect of Genetic Risk of Thromboembolic Disease in Inflammatory Bowel Disease.1 passage
• Prevalence and Morbidity of Undiagnosed Celiac Disease From a Community-Based Study.1 passage
• Prevalence of Advanced, Precancerous Colorectal Neoplasms in Black and White Populations: A Systematic Review and Meta-analysis.1 passage
• Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.1 passage
• Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis.1 passage
• Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.1 passage
• Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms.1 passage
• Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.1 passage
• Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.1 passage
• Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.1 passage
• Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.1 passage
• Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.1 passage
• Prevalence of and Factors Associated With Fecal Incontinence: Results From a Population-Based Survey.1 passage
• Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.1 passage
• Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis.1 passage
• Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.1 passage
• Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.1 passage
• Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn's Disease Compared With Reactive Monitoring.1 passage
• Probe-Based Confocal Laser Endomicroscopy for Indeterminate Bile Duct Strictures: The Inaccuracies of Accuracy When Appraising the Value of a Diagnostic Test.1 passage
• Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.1 passage
• Probiotics Reduce Mortality and Morbidity in Preterm, Low-Birth-Weight Infants: A Systematic Review and Network Meta-analysis of Randomized Trials.1 passage
• Probiotics and the Microbiome-How Can We Help Patients Make Sense of Probiotics?1 passage
• Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.1 passage
• Prognostic Utility of Total1 passage
• Progress in PD-1-based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers.1 passage
• Progression of Celiac Disease in Children With Antibodies Against Tissue Transglutaminase and Normal Duodenal Architecture.1 passage
• Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.1 passage
• Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.1 passage
• Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.1 passage
• Propensity for Intra-abdominal and Hepatic Adiposity Varies Among Ethnic Groups.1 passage
• Prophylactic Clipping After Colorectal Endoscopic Resection Prevents Bleeding of Large, Proximal Polyps: Meta-analysis of Randomized Trials.1 passage
• Prostaglandin E3 passages
• Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.1 passage
• Protective Role of Spermidine in Colitis and Colon Carcinogenesis.1 passage
• Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study.1 passage
• Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases.1 passage
• Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.1 passage
• Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with inflammatory bowel disease.1 passage
• Protocols, Personal Protective Equipment Use, and Psychological/Financial Stressors in Endoscopy Units During the COVID-19 Pandemic: A Large Survey of Hospital-Based and Ambulatory Endoscopy Centers in the United States.1 passage
• Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency.1 passage
• Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial.1 passage
• Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial.1 passage
• Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.1 passage
• Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia.1 passage
• Proton Pump Inhibitors and Chronic Kidney Disease: Is It Related to the Accumulation of Toxic Breakdown Products Spontaneously Formed in the Enteric-Protected Tablets?1 passage
• Providing the Best Care for Patients With Crohn's Disease: An Examination of the New AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.1 passage
• Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.1 passage
• Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.1 passage
• Quantification of Adequate Bowel Preparation for Screening or Surveillance Colonoscopy in Men.1 passage
• Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.1 passage
• RNA N1 passage
• RNA-Binding Protein HuR Regulates Paneth Cell Function by Altering Membrane Localization of TLR2 via Post-transcriptional Control of CNPY3.1 passage
• RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.1 passage
• Race/Ethnicity-, Socioeconomic Status-, and Anatomic Subsite-Specific Risks for Gastric Cancer.1 passage
• Racial Disparities in Incidence of Young-Onset Colorectal Cancer and Patient Survival.1 passage
• Racial Disparity in Gastrointestinal Cancer Risk.1 passage
• Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.1 passage
• Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women.1 passage
• Randomized Comparison of 3 High-Level Disinfection and Sterilization Procedures for Duodenoscopes.1 passage
• Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.1 passage
• Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome.1 passage
• Rapamycin Inhibition of mTOR Reduces Levels of the Na+/H+ Exchanger 3 in Intestines of Mice and Humans, Leading to Diarrhea.1 passage
• Rates of Incomplete Resection of 1- to 20-mm Colorectal Polyps: A Systematic Review and Meta-Analysis.1 passage
• Re: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease.1 passage
• Real-Time Characterization of Diminutive Colorectal Polyp Histology Using Narrow-Band Imaging: Implications for the Resect and Discard Strategy.1 passage
• Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.1 passage
• Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.1 passage
• Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.1 passage
• Recent Advances in Autoimmune Pancreatitis.1 passage
• Recent Advances in Endoscopy.1 passage
• Recent Advances in Human Genetics and Epigenetics of Adiposity: Pathway to Precision Medicine?1 passage
• Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.1 passage
• Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.1 passage
• Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.1 passage
• Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.1 passage
• Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.1 passage
• Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.1 passage
• Rectal Indomethacin for Post-ERCP Pancreatitis Prophylaxis in Average Risk Patients: Too Early to Terminate and Too Early to Conclude.1 passage
• Rectal Nonsteroidal Anti-inflammatory Drugs to Reduce the Rate and Severity of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: Still Grappling With Fundamental Questions.1 passage
• Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.1 passage
• Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.1 passage
• Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis.1 passage
• Regarding: Shung et al: Validation of a Machine Learning Model That Outperforms Clinical Risk Scoring Systems for Upper Gastrointestinal Bleeding.1 passage
• Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.1 passage
• Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis.1 passage
• Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.1 passage
• Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.1 passage
• Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts.1 passage
• Regulation of Liver Metabolism by Autophagy.1 passage
• Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.1 passage
• Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.1 passage
• Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.1 passage
• Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.1 passage
• Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.1 passage
• Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.1 passage
• Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.1 passage
• Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.1 passage
• Reply to "Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies from Patients with Liver Disease": Implications for Transplant Chimerism.1 passage
• Report from the AGA Center for GI Innovation and Technology's Consensus Conference: Envisioning Next-Generation Paradigms in Colorectal Cancer Screening and Surveillance.1 passage
• Repression of MicroRNA Function Mediates Inflammation-associated Colon Tumorigenesis.1 passage
• Reserve Stem Cells in Intestinal Homeostasis and Injury.1 passage
• Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.1 passage
• Results of Early Transplantation for Alcohol-Related Cirrhosis: Integrated Addiction Treatment With Low Rate of Relapse.1 passage
• Retinoic Acid and Lymphotoxin Signaling Promote Differentiation of Human Intestinal M Cells.1 passage
• Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.1 passage
• Right-Sided Location Not Associated With Missed Colorectal Adenomas in an Individual-Level Reanalysis of Tandem Colonoscopy Studies.1 passage
• Risk Factor Profiles Differ for Cancers of Different Regions of the Colorectum.1 passage
• Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.1 passage
• Risk Factors for Early-Onset Colorectal Cancer.1 passage
• Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort.1 passage
• Risk of Advanced Adenomas in Siblings of Individuals With Advanced Adenomas: A Cross-Sectional Study.1 passage
• Risk of Colorectal Cancer and Cancer Related Mortality After Detection of Low-risk or High-risk Adenomas, Compared With No Adenoma, at Index Colonoscopy: A Systematic Review and Meta-analysis.1 passage
• Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.1 passage
• Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.1 passage
• Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry.1 passage
• Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.1 passage
• Risk of Obesity-Related Cardiometabolic Complications in Special Populations: A Crisis in Asians.1 passage
• Risk of Postpolypectomy Bleeding With Uninterrupted Clopidogrel Therapy in an Industry-Independent, Double-Blind, Randomized Trial.1 passage
• Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.1 passage
• Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease.1 passage
• Risks Associated With Anesthesia Services During Colonoscopy.1 passage
• Risks of Bleeding Recurrence and Cardiovascular Events With Continued Aspirin Use After Lower Gastrointestinal Hemorrhage.1 passage
• Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.1 passage
• Robust, 3-Dimensional Visualization of Human Colon Enteric Nervous System Without Tissue Sectioning.1 passage
• Role of Autophagy in the Maintenance of Intestinal Homeostasis.1 passage
• Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.1 passage
• Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.1 passage
• Roles for Interleukin 17 and Adaptive Immunity in Pathogenesis of Colorectal Cancer.1 passage
• Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.1 passage
• Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction (DGBI).1 passage
• Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome.1 passage
• Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.1 passage
• S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants.1 passage
• SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.1 passage
• SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.1 passage
• SP and KLF Transcription Factors in Digestive Physiology and Diseases.1 passage
• SPDEF Induces Quiescence of Colorectal Cancer Cells by Changing the Transcriptional Targets of β-catenin.1 passage
• STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.1 passage
• Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.1 passage
• Safety and Efficacy of AJM300, an Oral Antagonist of α4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis.1 passage
• Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis.1 passage
• Safety of Adding Oats to a Gluten-Free Diet for Patients With Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies.1 passage
• Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis.1 passage
• Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.1 passage
• Screening for Barrett's Esophagus.1 passage
• Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes.1 passage
• Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.1 passage
• Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus.1 passage
• Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett’s Esophagus Li Xiaodun 1∗Kleeman Sam 1∗Coburn36 passages
• Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.1 passage
• Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal Cancer.1 passage
• Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.1 passage
• Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.1 passage
• Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.1 passage
• Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.1 passage
• Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.1 passage
• Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.1 passage
• Severe Acute Respiratory Syndrome Coronavirus 2 Attachment Receptor Angiotensin-Converting Enzyme 2 Is Decreased in Crohn's Disease and Regulated By Microbial and Inflammatory Signaling.1 passage
• Severe Inflammatory Bowel Disease Flares and COVID-19: Expand the Gastroenterology-Surgery Team to Include an Infectious Disease Specialist.1 passage
• Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.1 passage
• Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.1 passage
• Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.1 passage
• Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis.1 passage
• Signatures of Mutational Processes and Associated Risk Factors in Esophageal Squamous Cell Carcinoma: A Geographically Independent Stratification Strategy?1 passage
• Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.1 passage
• Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.1 passage
• Simple Sugar and Sugar-Sweetened Beverage Intake During Adolescence and Risk of Colorectal Cancer Precursors.1 passage
• Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.1 passage
• Simulation-Based Mastery Learning With Virtual Coaching: Experience in Training Standardized Upper Endoscopy to Novice Endoscopists.1 passage
• Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.1 passage
• Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.1 passage
• Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.1 passage
• Single-Cell RNA Sequencing of Blood and Ileal T Cells From Patients With Crohn's Disease Reveals Tissue-Specific Characteristics and Drug Targets.1 passage
• Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus.1 passage
• Single-Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells From Ulcerative Colitis Patients.1 passage
• Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury.1 passage
• Single-Nucleus and In Situ RNA-Sequencing Reveal Cell Topographies in the Human Pancreas.1 passage
• Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.1 passage
• Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.1 passage
• Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.1 passage
• Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.1 passage
• Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.1 passage
• Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.1 passage
• Solute Carrier Organic Anion Transporter Family Member 3A1 Is a Bile Acid Efflux Transporter in Cholestasis.1 passage
• Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.1 passage
• Sperm Flagellar 1 Binds Actin in Intestinal Epithelial Cells and Contributes to Formation of Filopodia and Lamellipodia.1 passage
• Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.1 passage
• Split-Dose Preparations Are Superior to Day-Before Bowel Cleansing Regimens: A Meta-analysis.1 passage
• Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.1 passage
• Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).1 passage
• Squalene Epoxidase Induces Nonalcoholic Steatohepatitis Via Binding to Carbonic Anhydrase III and is a Therapeutic Target.1 passage
• State of Evidence in Minimally Invasive Management of Gastroesophageal Reflux: Findings of a Scoping Review.1 passage
• Statin Use After Diagnosis of Colon Cancer and Patient Survival.1 passage
• Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study.1 passage
• Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.1 passage
• Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges.1 passage
• Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.1 passage
• Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.1 passage
• Stool Testing for Colorectal Cancer Screening.1 passage
• Strategies for Colorectal Cancer Screening.1 passage
• Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.1 passage
• Streptococcus thermophilus Inhibits Colorectal Tumorigenesis Through Secreting β-Galactosidase.1 passage
• Stromal Indian hedgehog signaling is required for intestinal adenoma formation in mice.1 passage
• Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.1 passage
• Succinate Produced by Intestinal Microbes Promotes Specification of Tuft Cells to Suppress Ileal Inflammation.1 passage
• Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.1 passage
• Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease.1 passage
• Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis.1 passage
• Supplementation of Diet With Galacto-oligosaccharides Increases Bifidobacteria, but Not Insulin Sensitivity, in Obese Prediabetic Individuals.1 passage
• Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.1 passage
• Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.1 passage
• Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.1 passage
• Sympathetic Input to Multiple Cell Types in Mouse and Human Colon Produces Region-Specific Responses.1 passage
• Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.1 passage
• Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.1 passage
• Synthetic Neoepitopes of the Transglutaminase-Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease.1 passage
• Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease.1 passage
• Systemic Inflammation in Preclinical Ulcerative Colitis.1 passage
• Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer.1 passage
• T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.1 passage
• TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study.1 passage
• TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.1 passage
• TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer.1 passage
• TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.1 passage
• TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.1 passage
• TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.1 passage
• TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice.1 passage
• TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease.1 passage
• TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.1 passage
• TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial.1 passage
• Take 2 Indomethacin (Suppositories) and Call Me in the Morning? The Role of Nonsteroidal Anti-inflammatory Drugs in Protection Against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.1 passage
• Targeted and Immune-Based Therapies for Hepatocellular Carcinoma.1 passage
• Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer.1 passage
• Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans.1 passage
• Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.1 passage
• Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative Colitis.1 passage
• Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters.1 passage
• Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China.1 passage
• Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.1 passage
• Terminology, Molecular Features, Epidemiology, and Management of Serrated Colorectal Neoplasia.1 passage
• Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.1 passage
• The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota Therapeutics.1 passage
• The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?1 passage
• The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.1 passage
• The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis.1 passage
• The Baseline Gut Microbiota Directs Dieting-Induced Weight Loss Trajectories.1 passage
• The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.1 passage
• The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling.1 passage
• The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature.1 passage
• The Combination of Alcohol and Cigarette Smoke Induces Endoplasmic Reticulum Stress and Cell Death in Pancreatic Acinar Cells.1 passage
• The Courage to Return to Everyday Life at the Time of COVID-19: The Point of View of Inflammatory Bowel Disease Patients Needing Endoscopy.1 passage
• The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.1 passage
• The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System.1 passage
• The Epidemiology of Esophageal Adenocarcinoma.1 passage
• The Evolving Genomic Landscape of Barrett's Esophagus and Esophageal Adenocarcinoma.1 passage
• The Functional Lumen Imaging Probe Detects Esophageal Contractility Not Observed With Manometry in Patients With Achalasia.1 passage
• The Gut Microbiome: Reaching the Promise Through Discovery- Advancing Knowledge and Discovery of the Gut Microbiome in the Age of Precision Medicine.1 passage
• The Healthy Microbiome-What Is the Definition of a Healthy Gut Microbiome?1 passage
• The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 and Promotes Tumorigenesis in Mice.1 passage
• The Importance of Accurate Phenotyping and Pouchitis Risk and Dietary Assessment When Investigating the Microbial Factors Behind Antibiotic-Dependent Pouchitis.1 passage
• The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance.1 passage
• The Influence of Different Types of Serum Cholesterol on the Prognosis of Hepatitis B Virus-Related Hepatocellular Patients Needs More Attention.1 passage
• The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling.1 passage
• The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.1 passage
• The Microbiota-Gut-Brain Axis: From Motility to Mood.1 passage
• The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care.1 passage
• The Optimal Age to Stop Endoscopic Surveillance of Patients With Barrett's Esophagus Based on Sex and Comorbidity: A Comparative Cost-Effectiveness Analysis.1 passage
• The Protective Effects of Calcineurin on Pancreatitis in Mice Depend on the Cellular Source.1 passage
• The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.1 passage
• The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.1 passage
• The Role of Phosphate in Alcohol-Induced Experimental Pancreatitis.1 passage
• The Role of Transforming Growth Factor-β in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications From an Integrative Multiomics Approach.1 passage
• The Role of the Endocannabinoid System in the Brain-Gut Axis.1 passage
• The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy.1 passage
• The Safety and Efficacy of an Alcohol-Free Pancreatic Cyst Ablation Protocol.1 passage
• The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.1 passage
• The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.1 passage
• The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.1 passage
• The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis.1 passage
• The Vagus Nerve in Appetite Regulation, Mood, and Intestinal Inflammation.1 passage
• The Value of a 24/7 Online Nationwide Multidisciplinary Expert Panel for Acute Necrotizing Pancreatitis.1 passage
• The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosis.1 passage
• The different immune profiles of normal colonic mucosa in cancer-free Lynch syndrome carriers and Lynch syndrome colorectal cancer patients.1 passage
• The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells.1 passage
• The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis.1 passage
• Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease.1 passage
• Therapeutic Landscape for NAFLD in 2020.1 passage
• Therapeutic Targeting of the Colorectal Tumor Stroma.1 passage
• Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection.1 passage
• Thirty-Day Readmission Among Patients With Non-Variceal Upper Gastrointestinal Hemorrhage and Effects on Outcomes.1 passage
• Three-Dimensional Pressure Profile of the Lower Esophageal Sphincter and Crural Diaphragm in Patients with Achalasia Esophagus.1 passage
• Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.1 passage
• Timeline of development of pancreatic cancer and implications for successful early detection in high-risk individuals.1 passage
• Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.1 passage
• Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.1 passage
• Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond.1 passage
• Transcription and DNA Methylation Patterns of Blood-Derived CD81 passage
• Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.1 passage
• Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.1 passage
• Transforming Gastroenterology Care With Telemedicine.1 passage
• Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.1 passage
• Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.1 passage
• Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.1 passage
• Transgenic Expression of PRSS11 passage
• Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.1 passage
• Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.1 passage
• Treatment of Active Crohn's Disease With an Ordinary Food-based Diet That Replicates Exclusive Enteral Nutrition.1 passage
• Treatment of Hypohepatia After Transplantation of Liver From a Living Donor Liver by Transcatheter Embolization, Using a Simulated 3-Dimensional Printing Vascular Model.1 passage
• Treatment of Intestinal Fibrosis in Experimental Inflammatory Bowel Disease by the Pleiotropic Actions of a Local Rho Kinase Inhibitor.1 passage
• Treatment of Severe Alcoholic Hepatitis.1 passage
• Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.1 passage
• Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.1 passage
• Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.1 passage
• Tropheryma whipplei Increases Expression of Human Leukocyte Antigen-G on Monocytes to Reduce Tumor Necrosis Factor and Promote Bacterial Replication.1 passage
• Tropism for Spasmolytic Polypeptide-Expressing Metaplasia Allows Helicobacter pylori to Expand Its Intragastric Niche.1 passage
• Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease.1 passage
• Truncating mutation in the nitric oxide synthase 1 gene is associated with infantile achalasia.1 passage
• Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D1 passage
• Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.1 passage
• Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.1 passage
• Tumor Seeding During Colonoscopy as a Possible Cause for Metachronous Colorectal Cancer.1 passage
• Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.1 passage
• Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses.1 passage
• Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.1 passage
• Underpowered PANTS: A Response to the Conclusions of "Extended Analysis Identifies Drug-Specific Association of Two Distinct HLA Class II Haplotypes for Development of Immunogenicity to Adalimumab and Infliximab".1 passage
• Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.1 passage
• Underwater vs Conventional Endoscopic Mucosal Resection of Large Sessile or Flat Colorectal Polyps: A Prospective Randomized Controlled Trial.1 passage
• Unique genomic profile of fibrolamellar hepatocellular carcinoma.1 passage
• Unit, NIHR Royal Liverpool University Hospital, Liverpool L69 3GA, United Kingdom. fax: (44)151-706-5826. r.sutton@liverpool.ac.uk1 8 2015 8 2015 149 2 481 492.e7 24 7 2014 20 4 2015 © 201539 passages
• Unplanned Hospital Encounters After Endoscopic Retrograde Cholangiopancreatography in 3 Large North American States.1 passage
• Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.1 passage
• Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.1 passage
• Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer.1 passage
• Uptake of Colorectal Cancer Screening by Physicians Is Associated With Greater Uptake by Their Patients.1 passage
• Use of Endoscopic Impression, Artificial Intelligence, and Pathologist Interpretation to Resolve Discrepancies Between Endoscopy and Pathology Analyses of Diminutive Colorectal Polyps.1 passage
• Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.1 passage
• Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer.1 passage
• Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms.1 passage
• Use of Single-Cell -Omic Technologies to Study the Gastrointestinal Tract and Diseases, From Single Cell Identities to Patient Features.1 passage
• Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.1 passage
• Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis.1 passage
• VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis.1 passage
• Validation and Comparison of Tools for Selecting Individuals to Screen for Barrett's Esophagus and Early Neoplasia.1 passage
• Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.1 passage
• Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy.1 passage
• Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.1 passage
• Validation of Recently Proposed Colorectal Cancer Susceptibility Gene Variants in an Analysis of Families and Patients-a Systematic Review.1 passage
• Validation of a Machine Learning Model That Outperforms Clinical Risk Scoring Systems for Upper Gastrointestinal Bleeding.1 passage
• Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.1 passage
• Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.1 passage
• Variants That Affect Function of Calcium Channel TRPV6 Are Associated With Early-Onset Chronic Pancreatitis.1 passage
• Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.1 passage
• Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn's Disease and Ulcerative Colitis.1 passage
• Variation in Interleukin 6 Receptor Gene Associates With Risk of Crohn’s Disease and Ulcerative Colitis Parisinos14 passages
• Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.1 passage
• Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.1 passage
• Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.1 passage
• Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation.1 passage
• Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.1 passage
• Virtual Endoscopy Based on 3-Dimensional Reconstruction of Histopathology Features of Endoscopic Resection Specimens.1 passage
• Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.1 passage
• Vitamin D Regulation of the Uridine Phosphorylase 1 Gene and Uridine-Induced DNA Damage in Colon in African Americans and European Americans.1 passage
• Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.1 passage
• Western Dietary Pattern Increases, and Prudent Dietary Pattern Decreases, Risk of Incident Diverticulitis in a Prospective Cohort Study.1 passage
• What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?1 passage
• What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.1 passage
• Wheat Consumption Aggravates Colitis in Mice via Amylase Trypsin Inhibitor-mediated Dysbiosis.1 passage
• White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study.1 passage
• Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.1 passage
• Why send your paper to Gastroenterology: global outreach and partnerships with sister journals, CGH and CMGH, among a menu of offerings.1 passage
• Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients.1 passage
• Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.1 passage
• World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer.1 passage
• Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer.1 passage
• Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study.1 passage
• X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.1 passage
• X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver.1 passage
• Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.1 passage
• Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.1 passage
• ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.1 passage
• ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.1 passage
• Zebrafish: an important tool for liver disease research.1 passage
• Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.1 passage
• mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.1 passage
• mTORC1 and mTORC2 Converge on the Arp2/3 Complex to Promote Kras1 passage
• miR-10b-5p Rescues Diabetes and Gastrointestinal Dysmotility.1 passage
• miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.1 passage
• microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients.1 passage
• microRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis.1 passage
• β-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis.1 passage
• γδ intraepithelial lymphocytes facilitate pathological epithelial cell shedding via CD103-mediated granzyme release.1 passage